BioSpace News Archive

AVM Biotechnology, LLC, a clinical stage company advancing AVM0703 in the treatment of Non-Hodgkin’s Lymphoma (NHL)/Leukemia, today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant.

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, announced significant expansion of coverage for lumbar total disc replacement procedures in Utah and Idaho.

The National Eczema Association announces it has been awarded a competitive grant from Pfizer in the amount of $175K to support its novel research study titled “Atopic Dermatitis Flares – An Understanding and Definition from the Patient Perspective.” The grant period commenced in January 2022 with a timeline of 18 months.

Tevogen Bio announced the strategic expansion of its leadership team with two new executives to support the biotech’s rapid operational growth, manufacturing readiness, and the continued development and utilization of its next generation precision T cell platform technology.

Rising prevalence of genetic diseases and neurodegenerative disorders, increasing number of studies and research programs on genetic engineering, and growing investments in research and development activities are some key factors expected to drive market growth.

The report further provides details about each segments and regions covered in the global Automated Breast Ultrasound System (ABUS) market. The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

The industry analysis report is considered a valuable source of information about the global Diabetes Injection Pens industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The report further provides details about each segments and regions covered in the global Joint Replacement market. The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

The industry analysis report is considered a valuable source of information about the global Tissue Expanders industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

CYTOO and Astellas Gene Therapies entered into a research collaboration in 2020 to select AGT’s AAV gene therapy clinical candidate to treat Duchenne Muscular Dystrophy.